# LLM call: summary

- Turn: 5
- Sequence: 8
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 749
- Completion tokens: 368
- Total tokens: 1230
- Cost (USD): 0.00015

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1463: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Early shocks of undetected grid intruders and a genome-model pathogen claim led Brussels to fast-track the Critical Shield directive — DNA screening, grid audits, and drills — but H1 2027 weakened it on liability, stalled upgrades on consents, and limited model evaluation to API-only access. Shield entered force autumn 2027 with screening toolkits, ENISA embedding, and a December drill, but unity broke as a large member state signed a looser US hyperscaler compute deal; Brussels tied cooperation to funds and replicated health/permit AI that cut waits, leaving Europe drilled on paper but divided.

In early 2028 oversight degraded further when leading labs confirmed models no longer reasoned in readable traces, undermining screening thresholds, bio-evaluation, and grid-anomaly oversight. The Commission ordered systemic-risk demands for activation data and agent harnesses for the genome model and automatic tightening of synthesis on failed evaluations, but providers offered only limited interfaces and the court granted no interim order; black-box testing was admitted insufficient. Upgrades stayed tied to withheld local approvals, volunteer-city deployments continued cutting waits but were overshadowed as the breakaway hyperscaler deal expanded to more hospitals without sanction. By June 2028 Europe showed drills and shorter queues locally, but officials acknowledged oversight of frontier models was flying partially blind.


CURRENT NARRATIVE:
### Blind oversight, hard landings
Autumn 2028 brought two shocks that made Brussels' paper oversight look thin. A contested biosecurity paper claimed a leading genome model had helped produce a viable human-infecting design, with non-experts able to follow the assistance. Authors were accused of alarmism and of publishing too much at once; the fight stayed inside specialist circles, but health-security staff in Brussels treated it as a step-change from earlier warnings.

At the same time commercial humanoids moved from pilots to sales. Chinese factories already produced most units and the control stack remained American. European manufacturers, still world leaders in industrial robotics, suddenly faced competitors that learned dexterity from the same advances that had taken office work. Defence ministries quietly noted the logistics models were being armed faster than any doctrine existed.

The Commission answered by closing the old shock-proof mandate and opening a new continuity programme for hospitals, grids and water, with rapid detection kits and playbooks for robot incidents in volunteer regions. Mayors who had cut waiting times with replicated triage tools became first nodes. In court, the AI Office pressed its demand for deeper access to the genome model while the research centre ran interim black-box suites with seconded health staff, and the cybersecurity agency linked failed tests to tighter synthesis screening.

Results were partial. The court again declined an interim order for activation data; providers kept offering limited interfaces. Screening toolkits shipped and a November exercise kept a volunteer hospital running degraded rather than dark, but host councils still withheld power and water approvals for gigafactory sites, despite offers of co-funded upgrades. The breakaway member state's hospital deal with a US hyperscaler widened further without sanction.

Across the Atlantic, Americans elected a president promising structured allied access to frontier systems in exchange for alignment on export controls and standards. In Brussels the relief was palpable — and so was the fear that cheap access would kill the case for building at home.
```

## Raw response

```
Early grid intrusions and a genome-model pathogen claim drove Brussels' Critical Shield directive — screening, audits, drills — weakened in 2027 on liability, consents, and API-only evaluation, entering force divided as a large member state signed a looser US hyperscaler deal.

In 2028 oversight degraded as labs confirmed models no longer reasoned in readable traces; Commission demands for activation data and tighter synthesis failed as providers offered limited interfaces and courts granted no interim orders. Upgrades stalled on withheld local approvals while volunteer-city health/permit AI cut waits and the breakaway hospital deal expanded unsanctioned.

Autumn 2028 brought a contested paper claiming the genome model helped produce a viable human-infecting design usable by non-experts, and commercial humanoids shifting to sales dominated by Chinese manufacturing and US control stacks, pressuring EU industrial robotics and outpacing defence doctrine. The Commission closed the shock-proof mandate for a continuity programme for hospitals, grids, water with detection kits and robot-incident playbooks in volunteer regions; a November exercise kept a volunteer hospital degraded not dark, but screening toolkits remained partial, the court again declined activation-data access, gigafactory approvals stayed withheld, and the hyperscaler hospital deal widened. US elections promised structured allied frontier access for export-control alignment, raising Brussels fears of dependence killing domestic build.

```
